Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Can high-spatial resolution T2-weighted endorectal MRI rule out clinically significant prostate cancer?

Roethke MC, Kniess M, Kaufmann S, Lichy MP, Schlemmer HP, Stenzl A, Schilling D.

World J Urol. 2014 Apr;32(2):379-83. doi: 10.1007/s00345-013-1106-3. Epub 2013 Jun 11.

PMID:
23754478
2.

Combining prostrate-specific antigen and Gleason score increases the diagnostic power of endorectal coil magnetic resonance imaging in prostate cancer pathological stage.

Tsao CW, Lin MH, Wu ST, Meng E, Tang SH, Chen HI, Sun GH, Yu DS, Chang SY, Cha TL.

J Chin Med Assoc. 2013 Jan;76(1):20-4. doi: 10.1016/j.jcma.2012.09.005. Epub 2012 Nov 23.

3.

[Preoperative endorectal MRI in prostate cancer: a monocentric retrospective cohort].

de Vendin C, Eydant Y, Ecochard R, Lorin S, Lacroix B, Lardon R, Mottet N.

Prog Urol. 2013 Dec;23(16):1412-8. doi: 10.1016/j.purol.2013.04.019. Epub 2013 Aug 27. French.

PMID:
24274946
4.

Accuracy of preoperative endorectal MRI in predicting extracapsular extension and influence on neurovascular bundle sparing in radical prostatectomy.

Roethke MC, Lichy MP, Kniess M, Werner MK, Claussen CD, Stenzl A, Schlemmer HP, Schilling D.

World J Urol. 2013 Oct;31(5):1111-6. doi: 10.1007/s00345-012-0826-0. Epub 2012 Jan 17.

PMID:
22249342
5.

[Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer].

Baccos A, Schiavina R, Zukerman Z, Busato F, Gaudiano C, Salizzoni E, Fiorentino M, Golfieri R, Martorana G.

Urologia. 2012 Apr-Jun;79(2):116-22. doi: 10.5301/RU.2012.9207. Italian.

6.

Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.

Liauw SL, Pitroda SP, Eggener SE, Stadler WM, Pelizzari CA, Vannier MW, Oto A.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):378-84. doi: 10.1016/j.ijrobp.2012.05.015. Epub 2012 Jun 18.

PMID:
22717242
7.

Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance.

Guzzo TJ, Resnick MJ, Canter DJ, Bivalacqua TJ, Rosen MA, Bergey MR, Magerfleisch L, Tomazewski JE, Wein AJ, Malkowicz SB.

Urol Oncol. 2012 May-Jun;30(3):301-5. doi: 10.1016/j.urolonc.2010.08.023.

PMID:
21856187
8.

[Significance of endorectal nuclear magnetic resonance tomography and transrectal ultrasound diagnosis in local staging of prostatic carcinoma].

May F, Treumann T, Dettmar P, Hartung R, Breul J.

Urologe A. 2002 Sep;41(5):458-61. German.

PMID:
12426863
9.

Impact of preoperative endorectal MRI stage classification on neurovascular bundle sparing aggressiveness and the radical prostatectomy positive margin rate.

Brown JA, Rodin DM, Harisinghani M, Dahl DM.

Urol Oncol. 2009 Mar-Apr;27(2):174-9. doi: 10.1016/j.urolonc.2008.04.009. Epub 2008 Jul 21.

PMID:
18640062
10.

Seminal vesicle invasion: accuracy and analysis of infiltration patterns with high-spatial resolution T2-weighted sequences on endorectal magnetic resonance imaging.

Roethke M, Kaufmann S, Kniess M, Ketelsen D, Claussen CD, Schlemmer HP, Stenzl A, Schilling D.

Urol Int. 2014;92(3):294-9. doi: 10.1159/000353968. Epub 2013 Nov 26.

PMID:
24296943
11.

Tumorsize dependent detection rate of endorectal MRI of prostate cancer--a histopathologic correlation with whole-mount sections in 70 patients with prostate cancer.

Roethke MC, Lichy MP, Jurgschat L, Hennenlotter J, Vogel U, Schilling D, Stenzl A, Claussen CD, Schlemmer HP.

Eur J Radiol. 2011 Aug;79(2):189-95. doi: 10.1016/j.ejrad.2010.01.014. Epub 2010 Mar 12.

PMID:
20227209
12.

Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.

Fütterer JJ, Engelbrecht MR, Huisman HJ, Jager GJ, Hulsbergen-van De Kaa CA, Witjes JA, Barentsz JO.

Radiology. 2005 Nov;237(2):541-9.

PMID:
16244263
13.

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.

Somford DM, Hamoen EH, Fütterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA.

J Urol. 2013 Nov;190(5):1728-34. doi: 10.1016/j.juro.2013.05.021. Epub 2013 May 13.

PMID:
23680307
14.
15.

Accuracy of MRI with an endorectal coil for staging endometrial cancer.

Alt CD, Brocker KA, Eichbaum M, Sohn C, Kopp-Schneider A, Kauczor HU, Hallscheidt P.

Acta Radiol. 2012 Jun 1;53(5):580-5. doi: 10.1258/ar.2012.110617. Epub 2012 Apr 25.

PMID:
22535884
16.

Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer.

D'Amico AV, Whittington R, Malkowicz B, Schnall M, Schultz D, Cote K, Tomaszewski JE, Wein A.

J Urol. 2000 Sep;164(3 Pt 1):759-63.

PMID:
10953141
17.

Inapparent tumor on endorectal multimodality magnetic resonance imaging of prostate: should we perform a biopsy?

Labanaris AP, Engelhard K, Zugor V, Witt JH, Kühn R.

Urology. 2011 Jul;78(1):116-20. doi: 10.1016/j.urology.2010.10.038. Epub 2011 Feb 18. Erratum in: Urology. 2014 May;83(5):1209.

PMID:
21333339
18.

Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.

Carlani M, Mancino S, Bonanno E, Finazzi Agrò E, Simonetti G.

Radiol Med. 2008 Aug;113(5):670-88. doi: 10.1007/s11547-008-0271-8. Epub 2008 May 20. English, Italian.

PMID:
18493829
19.

Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective, comparative study for preoperative staging and follow-up of rectal cancer.

Meyenberger C, Huch Böni RA, Bertschinger P, Zala GF, Klotz HP, Krestin GP.

Endoscopy. 1995 Sep;27(7):469-79.

PMID:
8565885
20.

Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.

Horiguchi A, Nakashima J, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M.

Prostate. 2003 Jun 15;56(1):23-9.

PMID:
12746843

Supplemental Content

Support Center